Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.331 $0.440 Thursday, 9th May 2024 GLMD stock ended at $0.415. This is 6.71% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 13.51% from a day low at $0.370 to a day high of $0.420.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Sep 15, 2016 $3.54 $3.74 $3.53 $3.62 26 200
Sep 14, 2016 $3.61 $3.80 $3.60 $3.60 4 600
Sep 13, 2016 $3.62 $3.70 $3.55 $3.65 13 000
Sep 12, 2016 $3.78 $3.78 $3.60 $3.63 23 600
Sep 09, 2016 $3.90 $3.90 $3.80 $3.80 5 500
Sep 08, 2016 $3.90 $4.02 $3.89 $3.97 21 300
Sep 07, 2016 $3.85 $4.00 $3.85 $3.93 22 800
Sep 06, 2016 $3.85 $4.03 $3.85 $3.96 30 500
Sep 02, 2016 $3.83 $3.94 $3.78 $3.85 28 200
Sep 01, 2016 $3.84 $3.86 $3.80 $3.80 11 500
Aug 31, 2016 $3.85 $3.96 $3.80 $3.85 37 100
Aug 30, 2016 $3.93 $3.99 $3.80 $3.81 17 600
Aug 29, 2016 $3.82 $3.99 $3.74 $3.97 20 300
Aug 26, 2016 $3.75 $3.87 $3.73 $3.78 9 200
Aug 25, 2016 $3.81 $3.89 $3.70 $3.70 25 700
Aug 24, 2016 $3.99 $4.00 $3.81 $3.85 24 600
Aug 23, 2016 $4.00 $4.05 $3.91 $3.95 37 300
Aug 22, 2016 $4.05 $4.07 $3.76 $3.89 48 900
Aug 19, 2016 $4.03 $4.05 $3.90 $3.99 10 900
Aug 18, 2016 $4.08 $4.09 $3.95 $4.01 13 600
Aug 17, 2016 $4.14 $4.16 $3.89 $4.08 62 700
Aug 16, 2016 $4.15 $4.16 $4.10 $4.14 6 900
Aug 15, 2016 $4.02 $4.16 $3.91 $4.03 31 200
Aug 12, 2016 $4.23 $4.24 $4.00 $4.06 34 100
Aug 11, 2016 $4.15 $4.15 $4.11 $4.13 2 500
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT